Showing results (311-320 of 523) with videos related to

Sort By:
Pageof 53
Lung Cancer (Amsterdam, Netherlands)|February 2, 2024
International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG studyThierry J Molina, Anja C Roden, Malgorzata Szolkowska, et al.
Annals of the Rheumatic Diseases|June 11, 2017
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatmentRakiba Belkhir, Sébastien Le Burel, Laetitia Dunogeant, et al.
Cancers|October 27, 2022
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI ScoreMonica Pierro, Capucine Baldini, Edouard Auclin, et al.
Pathology, Research and Practice|November 5, 2015
Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypesVincent Thomas de Montpréville, Pauline Quilhot, Lara Chalabreysse, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancerByoung Chul Cho, Grace K Dy, Ramaswamy Govindan, et al.
Virchows Archiv : an International Journal of Pathology|April 15, 2021
Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)Francesca Fenizia, Nicola Wolstenholme, Jennifer A Fairley, et al.
Journal for Immunotherapy of Cancer|May 26, 2022
Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodiesMathieu Larroquette, Jean-Philippe Guegan, Benjamin Besse, et al.
Cell Cycle (Georgetown, Tex.)|January 25, 2013
Prognostic value of LIPC in non-small cell lung carcinomaLorenzo Galluzzi, Aicha Goubar, Ken André Olaussen, et al.
JAMA Network Open|February 3, 2026
Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-AnalysisJonas Willmann, Camilla von Wachter, Ronja Zehnder, et al.
Lung Cancer (Amsterdam, Netherlands)|January 10, 2024
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastasesSolange Peters, José Trigo, Benjamin Besse, et al.
Pageof 53